COLLABORATION AGREEMENT BY AND BETWEEN MOMENTA PHARMACEUTICALS, INC. AND MYLAN IRELAND LIMITED, DATED AS OF JANUARY 8, 2016 Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and...Collaboration Agreement • February 3rd, 2017 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Collaboration Agreement (the “Agreement”), executed as of January 8, 2016 (the “Execution Date”), is made by and between Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta”), with a principal place of business at 675 West Kendall Street, Cambridge, Massachusetts 02142, and Mylan Ireland Limited, a limited company organized under the laws of Ireland (“Mylan”), with a principal place of business at South Bank House, Barrow Street, 6th Floor, Dublin 4, Ireland. Momenta and Mylan may each be referred to individually as a “Party” or, collectively, the “Parties”.
